ARCHIVES

Linda Weiss, director of NCI Office of Cancer Centers, to Retire in March 2015

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Controversy Continues, Scientists, Advocates, Clinicians Say

January 31, 1997

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990

Annual Report Finds Decreases In Overall Cancer Rates

December 11, 2009

Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed

April 4, 1980

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986